NavioMD review
A same-day-provider-access platform offering compounded tirzepatide from $189/mo alongside brand-name Ozempic/Zepbound/Mounjaro access — but no compounded semaglutide option, so semaglutide-specific readers pay brand-name prices starting at $345/mo.
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
NavioMD at a glance
- Semaglutide
- Ozempic® from $345/mo
- Tirzepatide
- Compounded from $189/mo
- Coverage
- 48 states (not AL or MS)
- Brand-name
- Yes
How we scored NavioMD
Each factor is scored from NavioMD's real pricing, disclosures and oversight, then combined into the 58/100 Editors' Rating by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Limited public detail on who oversees care and how.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- naviomd.com
Sourced from WLR's provider directory, independently re-verified live on naviomd.com (2026-08-03). All four tiered starting prices (compounded tirzepatide, Ozempic, Zepbound, Mounjaro) confirmed directly on the homepage pricing grid, matching WLR's recorded figures. The 48-state coverage (excluding AL, MS) confirmed via the site's own FAQ. Named pharmacy partner (The Pharmacy Hub) also confirmed via FAQ.
What to expect when you sign up
We walked NavioMD's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Homepage leads with 'Meet with a provider instantly' and a tiered pricing grid for both compounded tirzepatide and brand-name Ozempic/Zepbound/Mounjaro
- 2Also offers a women's-hormone menu (progesterone capsules, Biest) alongside weight loss, on the same site
- 3FAQ names its exclusive pharmacy partner directly — The Pharmacy Hub — for both compounded and branded medication fulfillment
- 4States operation in 48 states, explicitly excluding Alabama and Mississippi, with automatic eligibility verification during intake
What we noticed
- No compounded semaglutide option was found on this site — readers wanting semaglutide specifically would need to go the brand-name Ozempic route at a meaningfully higher price ($345/mo vs $189/mo for compounded tirzepatide)
- Same-day provider access is a genuine claim — 'available instantly from the hours of 9am-10pm EST'
- Names its pharmacy partner directly (The Pharmacy Hub), a real transparency plus
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS, despite the site's parallel women's-hormone menu
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded tirzepatide | $189 | As low as, tiered by doseListed as 'as low as $189/month'; no compounded semaglutide option was found — semaglutide is only offered as brand-name Ozempic on this site. |
| Brand semaglutide | $345 | Ozempic®, as low as, tiered by doseListed as 'as low as $345/month.' |
| Brand tirzepatide | $445 | Zepbound®, as low as, tiered by doseListed as 'as low as $445/month.' |
| Brand tirzepatide | $1249 | Mounjaro®, as low as, tiered by doseListed as 'as low as $1,249/month' — Mounjaro is tirzepatide's diabetes-indication brand name, listed separately from Zepbound (the weight-loss-indication brand of the same molecule) at a much higher price point. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect NavioMD's public disclosures at last review and change often; confirm the current number on NavioMD's own site.
What we like
- Same-day, instant provider access, per the site — one of the faster claimed timelines in this round
- Names its exclusive pharmacy partner (The Pharmacy Hub) directly
- Offers brand-name Ozempic®, Zepbound®, and Mounjaro® alongside compounded tirzepatide
- Parallel women's-hormone menu (progesterone, Biest) on the same platform
The caveats
- No compounded semaglutide option — semaglutide is only available as brand-name Ozempic at a much higher price
- Not available in Alabama or Mississippi
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS, despite the parallel women's-hormone menu
- No published statement on whether a video visit is required
NavioMD for mothers: our verdict
A same-day-provider-access platform offering compounded tirzepatide from $189/mo alongside brand-name Ozempic/Zepbound/Mounjaro access — but no compounded semaglutide option, so semaglutide-specific readers pay brand-name prices starting at $345/mo. It runs about $189/month — a premium to the category, so the extras have to earn it.
We weigh NavioMD the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the parts a generic weight-loss review skips.
What NavioMD actually costs
- Compounded tirzepatide — As low as, tiered by dose: $189/mo
- Brand-name semaglutide — Ozempic®, as low as, tiered by dose: $345/mo
- Brand-name tirzepatide — Zepbound®, as low as, tiered by dose: $445/mo
- Brand-name tirzepatide — Mounjaro®, as low as, tiered by dose: $1249/mo
For context, the typical ongoing price across our roster is around $149/month, so NavioMD sits at the premium end.
The medications NavioMD prescribes
NavioMD prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own pregnancy and lactation labeling, which is cleaner to hand to an OB.
Where NavioMD fits — and where it doesn't — for mothers
A good fit if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
NavioMD is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers open to tirzepatide specifically, or comfortable paying brand-name pricing for semaglutide, who want to talk to a provider the same day rather than wait for async review.
Alternatives to NavioMD
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing NavioMD
Head-to-head & alternatives
NavioMD, answered
- How much does NavioMD cost?
- As last verified, NavioMD's compounded pricing starts around $189/month (Ozempic® from $345/mo semaglutide, Compounded from $189/mo tirzepatide). Confirm the current, all-in price on NavioMD's own site before you commit.
- Is NavioMD safe to use while breastfeeding?
- No GLP-1 — compounded or brand — is established as safe during pregnancy or breastfeeding, and the labels advise against use; NavioMD is no exception. Plan any GLP-1 for after weaning, and discuss the timing with your own clinician.
- Does NavioMD offer both semaglutide and tirzepatide?
- Yes — NavioMD offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does NavioMD rank for mothers?
- NavioMD scores 58/100 on our Editors' Rating (rank #60), which weights six factors that matter for mothers. Our #1 pick, CoreAge Rx, leads the ranking — see how they compare.
Pricing, states and verification reflect NavioMD's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.